Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Usefulness of Intracoronary Epinephrine in Severe Hypotension during Percutaneous Coronary Interventions

  • Choi, Jin Hee (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Chun, Kook-Jin (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Lee, Sang Hyun (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Chon, Min Ku (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Lee, Sang-Gwon (Division of Cardiology, Department of Thoracic & Cardiovascular Surgery, Pusan National University Yangsan Hospital) ;
  • Kim, Jeong Su (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Jun (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Park, Yong-Hyun (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, June Hong (Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital)
  • Received : 2013.07.17
  • Accepted : 2013.09.25
  • Published : 2013.11.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Life-threatening hypotension during percutaneous coronary interventions (PCI) is devastating for the patient and is associated with fatal adverse outcomes. The aim of our study was to assess the usefulness of intracoronary epinephrine in severe hypotension unresponsive to other measures during PCI. Subjects and Methods: We analyzed the Pusan National University Yangsan hospital cardiac catheterization laboratory database to identify patients who underwent PCI from December 2008 to July 2012. The outcomes were changes of blood pressure (BP) and heart rate (HR) before and after intracoronary epinephrine and in-hospital mortality. Results: A total of 30 patients who were initially stable and received intracoronary epinephrine for severe hypotension during PCI were included. Following administration of intracoronary epinephrine (dose $181{\pm}24.8$ microgram), systolic and diastolic BP (from $53.8{\pm}13.0$ mm Hg up to $112.8{\pm}21.2$ mm Hg, from $35{\pm}7.6$ mm Hg up to $70.6{\pm}12.7$ mm Hg, respectively) and HR (from $39.4{\pm}5.1$ beats/min up to $96.8{\pm}29.3$ beats/min) were increased. Additionally, 21 patients (70%) showed hemodynamically acceptable responses to intracoronary epinephrine without the intraaortic balloon pump and temporary pacemaker during the PCI. In-hospital mortality was 17% (n=5). Conclusion: Although our study was small, intracoronary epinephrine was found to be well tolerated and resulted in prompt and successful recovery from severe hypotension in most patients when other measures were ineffective. Intracoronary epinephrine could be a safe and useful measure in patients developing severe hypotension during PCI.

Keywords

References

  1. Skelding KA, Goldstein JA, Mehta L, Pica MC, O'Neill WW. Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv 2002;57:305-9. https://doi.org/10.1002/ccd.10303
  2. Kahn JK, Hartzler GO. Reversal of refractory hypotension with intracoronary epinephrine during coronary angioplasty. Am Heart J 1993;126: 463-6. https://doi.org/10.1016/0002-8703(93)91073-N
  3. Brunton LL, Chabner BA, Knollmann BC. Adrenergic agonists and antagonists. In: Brunton LL, editor. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th ed. McGraw-Hill;2010. p.282-7.
  4. Otto CW, Yakaitis RW. The role of epinephrine in CPR: a reappraisal. Ann Emerg Med 1984;13(9 Pt 2):840-3. https://doi.org/10.1016/S0196-0644(84)80455-2
  5. Zhong JQ, Dorian P. Epinephrine and vasopressin during cardiopulmonary resuscitation. Resuscitation 2005;66:263-9. https://doi.org/10.1016/j.resuscitation.2005.02.014
  6. Kitsou V, Xanthos T, Stroumpoulis K, et al. Nitroglycerin and epinephrine improve coronary perfusion pressure in a porcine model of ventricular fibrillation arrest: a pilot study. J Emerg Med 2009;37:369-75. https://doi.org/10.1016/j.jemermed.2008.07.003
  7. Grmec S, Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study. Crit Care 2006; 10:R13. https://doi.org/10.1186/cc3967
  8. Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982;65:281-5. https://doi.org/10.1161/01.CIR.65.2.281
  9. Kiss G, Corre O, Gueret G, et al. Management of cardiac arrest caused by coronary artery spasm: epinephrine/adrenaline versus nitrates. Heart Lung 2009;38:228-32. https://doi.org/10.1016/j.hrtlng.2008.04.005
  10. Baim DS. Epinephrine: a new pharmacologic treatment for no-reflow? Catheter Cardiovasc Interv 2002;57:310-1. https://doi.org/10.1002/ccd.10320
  11. Comroe JH. Nonrespiratory functions of the lungs and circulation. Physiology of respiration. 2nd ed. Chicago: Year Book Medical Publishers; 1974. p.285-92.
  12. Aral A, Oguz M, Ozberrak H, et al. Hemodynamic advantages of left atrial epinephrine administration in open heart operations. Ann Thorac Surg 1997;64:1046-9. https://doi.org/10.1016/S0003-4975(97)00798-4
  13. Lucreziotti S, Sponzilli C, Castini D, Di Domenico E, Fiorentini C. Intracoronary epinephrine for contrast-medium-induced microvascular obstruction in a chronically hemodialyzed patient. Cardiology 2005;103: 196-8. https://doi.org/10.1159/000085127

Cited by

  1. (Use of intracoronary epinephrine in a patient with noflow phenomenon in cardiogenic shock - case report) vol.62, pp.5, 2013, https://doi.org/10.33678/cor.2019.062